Quick exitLeave this site quickly

Medicines A–Z

Every medicine used in gender-affirming hormone therapy in Australia, plus the medicines commonly used alongside it — with an in-depth page for each: how it is used, what it costs, what is monitored, and where it sits for supply.

← Back to supply & shortages

Stock seen by patients

What people have reported seeing on pharmacy shelves, newest first and grouped by medicine. All patient sightings are unverified: they are reports from the public, not confirmed stock levels. Always ring the pharmacy before travelling. To have a report removed, use the feedback page (preferred) or email [email protected].

Share a sighting →

← Back to all medicines

Finasteride

A tablet that blocks testosterone being changed into dihydrotestosterone (DHT) in the scalp. It is an emerging option for pattern (androgenic) hair loss in people on testosterone. It is also commonly used in feminising care.

Finasteride · sold as Finasteride GH 1, Propecia, APO-Finasteride 1, Finapen

Available in Australia?Limited supplyNot every brand or strength. TGA records checked 21 Nov 2026.See supply detail

What it is

Finasteride is a 5-alpha reductase inhibitor[2]. It blocks the enzyme (a type of protein) that turns testosterone into dihydrotestosterone (DHT)[2]. DHT is the form most responsible for shrinking scalp hair roots (follicles) in pattern (androgenic) hair loss[2].

Testosterone therapy can bring on or worsen this pattern of scalp thinning over time. Australia's 2026 standards of care note the evidence in trans men specifically[1]. They describe a small retrospective case review (a study looking back at past patients' records)[1]. In it, low-dose finasteride in trans men led to modest improvements in hair loss[1]. There were no reports of sexual side effects[1]. The same document also covers this drug class in cisgender men[1]. It says "the use of 5ARI in cis men has been associated with sexual side effects, depression and suicidal thoughts"[1]. 5ARI is short for 5-alpha reductase inhibitor, the group finasteride belongs to. Those sexual side effects haven't been reported in that small trans-specific study[1]. But the evidence base is still limited[1].

It works differently from spironolactone or cyproterone. These are the anti-androgens (testosterone-blocking medicines) used in feminising therapy on this site. Finasteride targets one specific enzyme in hair follicles. It does not block androgen receptors (the parts of cells testosterone acts on) more broadly.

Gender-Affirming Medicines South Australia

Clear, referenced information on gender-affirming medicines in South Australia — hormones, blockers and everything that happens at the pharmacy — for our community, and the people who care for, prescribe and dispense them.

What do you need today?

Guides

  • ReferencedSources cited on every guide
  • Pharmacist-writtenBy a registered pharmacist in Adelaide
  • Kept currentSupply checked daily from TGA records; PBS prices monthly
  • PrivateNo cookies, no tracking, Quick exit

Looking for a prescriber?

The Trans Health SA directory lists GPs, clinics and services across South Australia. Your pharmacist can also tell you which local prescribers regularly prescribe gender-affirming hormones.

Supply & shortages

Which hormone therapy medicines are hard to get in Australia right now, and what it means for you.

No supply problems reported

    Pharmacy stock reports

    What registered pharmacists say is on their shelves right now, checked against the AHPRA register before publishing. The official data above tells you about Australia; this tells you about particular pharmacies.

    See all pharmacy stock reports   Pharmacists: post a report →

    Seen it in stock, or missed out?

    Reports from other patients about what their local pharmacy had on the shelf. This sits alongside the official data above until a verified pharmacy stock feed is in place.

    Anonymous. No account, no personal details, and please don't put a person's name in the note.

    If your medicine is affected

    Start with your pharmacist — they can check other suppliers, order it in, and for the oestrogen patches can often supply an approved alternative without a new prescription. Filling your script a few days early, rather than on the last day, gives everyone room to move.

    ← Back to supply & shortages

    Pharmacy stock reports

    Stock reports posted by registered pharmacists, newest first. Each pharmacist's registration number is checked against the AHPRA register before their first report is published; after that their reports appear straight away.

    Post a report

    For pharmacists, and pharmacy staff posting on a pharmacist's behalf. Your name, registration number and work email (if you give one) are stored, and only the author can see them. Your registration number is never shown. The pharmacy name, suburb, medicine, stock position and note are public. To correct or remove a report, use the feedback page (preferred) or email [email protected].

    Not for promoting your pharmacy: report stock facts only. By posting you confirm you are a registered pharmacist, or are posting with one's permission, and that the report is accurate at the time of posting. Reports expire after 14 days.

    Send feedback

    Spotted something wrong, out of date or missing? Tell us here. Every message is read, and corrections are made as quickly as possible. The form is the preferred way to reach us; if you cannot use it, email [email protected].

    Please do not include personal health details. Messages are stored privately and never shared, and no tracking cookies are used.